SUNPHARMA2021-07-012021-09-30in-bse-fin:OneOperatingExpenses01Member SUNPHARMA2021-07-012021-09-30in-bse-fin:OneOperatingExpenses02Member SUNPHARMA2021-07-012021-09-30in-bse-fin:FourOperatingExpenses01Member SUNPHARMA2021-07-012021-09-30in-bse-fin:FourOperatingExpenses02Member SUNPHARMA2021-07-012021-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member SUNPHARMA2021-07-012021-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member SUNPHARMA2021-07-012021-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member SUNPHARMA2021-07-012021-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares SUNPHARMA 2021-04-01 2022-03-31 2021-10-12 INR Millions Half yearly true Cash Flow Indirect Single segment Pharmaceuticals 2021-07-01 2021-09-30 Unaudited Standalone 41431500000.00 2842700000.00 44274200000.00 10923000000.00 2854400000.00 484200000.00 5090700000.00 1039800000.00 3336400000.00 13436500000.00 37165000000.00 7109200000.00 0.00 7109200000.00 -981500000.00 0.00 -981500000.00 0.00 8090700000.00 0.00 0.00 0.00 0.00 8090700000.00 -1011400000.00 7079300000.00 7079300000.00 0.00 2399300000.00 1 3.40 3.40 0.00 0.00 3.40 3.40 0.00 0.04 0.08 Particulars Quarter Ended Half Year Ended 30.09.2021 30.09.2021 Reasearch and Development Expenses incurred (included above) 4088.3 8450.4 Notes to Cash Flow statement Repayment of borrowings includes payment of lease obligation. It shows unaudited standalone cash flow statement for the half year ended September 30,2021 Single segment 2021-04-01 2021-09-30 Unaudited Standalone 78084400000.00 3522800000.00 81607200000.00 21716800000.00 6854400000.00 -79500000.00 10010500000.00 2114400000.00 6405700000.00 27069300000.00 74091600000.00 7515600000.00 -1655700000.00 5859900000.00 -848000000.00 0.00 -848000000.00 0.00 6707900000.00 0.00 0.00 0.00 0.00 6707900000.00 -843500000.00 5864400000.00 5864400000.00 0.00 2399300000.00 1 2.80 2.80 0.00 0.00 2.80 2.80 0.00 0.02 0.05 Net (gain) / loss on foreign currency transactions 528200000.00 Other Expenses 12908300000.00 Net (gain) / loss on foreign currency transactions -908600000.00 Other Expenses 27977900000.00 2114400000.00 1168200000.00 7311600000.00 0.00 2722900000.00 0.00 0.00 0.00 0.00 -11938300000.00 0.00 1102700000.00 0.00 6405700000.00 0.00 -2259100000.00 0.00 0.00 0.00 -1508700000.00 0.00 1373400000.00 0.00 -200000.00 0.00 1456100000.00 0.00 -33900000.00 0.00 5168000000.00 11027900000.00 0.00 0.00 0.00 584000000.00 0.00 10443900000.00 0.00 0.00 46610700000.00 43033200000.00 0.00 0.00 0.00 0.00 54300000.00 6437000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8069000000.00 0.00 0.00 102800000.00 -10000000.00 0.00 0.00 0.00 5356600000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21212700000.00 22793700000.00 0.00 0.00 4812100000.00 196600000.00 0.00 0.00 -6589700000.00 9210800000.00 58400000.00 9269200000.00 3510600000.00 12779800000.00